Literature DB >> 24971768

Vascular endothelial growth factor-A is associated with chronic mountain sickness in the Andean population.

Jose R Espinoza1, Giancarlo Alvarez, Fabiola León-Velarde, Hugo F Ju Preciado, Jose-Luis Macarlupu, Maria Rivera-Ch, Jorge Rodriguez, Judith Favier, Anne-Paule Gimenez-Roqueplo, Jean-Paul Richalet.   

Abstract

A study of chronic mountain sickness (CMS) with a candidate gene--vascular endothelial growth factor A (VEGFA)--was carried out in a Peruvian population living at high altitude in Cerro de Pasco (4380 m). The study was performed by genotyping of 11 tag SNPs encompassing 2.2 kb of region of VEGFA gene in patients with a diagnosis of CMS (n = 131; 49.1 ± 12.7 years old) and unrelated healthy controls (n = 84; 47.2 ± 13.4 years old). The VEGFA tag SNP rs3025033 was found associated with CMS (p < 0.05), individuals with AG genotype have 2.5 more risk of CMS compared to those with GG genotype (p < 0.02; OR, 2.54; 95% CI: 1.10-5.88). Pairwise Fst and Nei's distance indicate genetic differentiation between Cerro de Pasco population and HapMap3 population (Fst > 0.36, p < 0.01), suggesting selection is operating on the VEGF gene. Our results suggest that VEGFA is associated with CMS in long-term residents at high altitude in the Peruvian Andes.

Entities:  

Keywords:  VEGF; association; chronic mountain sickness; genetics; high altitude

Mesh:

Substances:

Year:  2014        PMID: 24971768      PMCID: PMC4074753          DOI: 10.1089/ham.2013.1121

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  43 in total

Review 1.  Tibetan and Andean patterns of adaptation to high-altitude hypoxia.

Authors:  C M Beall
Journal:  Hum Biol       Date:  2000-02       Impact factor: 0.553

2.  Proposal for scoring severity in chronic mountain sickness (CMS). Background and conclusions of the CMS Working Group.

Authors:  Fabiola León-Velarde; Rosann G McCullough; Robert E McCullough; John T Reeves
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

3.  2LD, GENECOUNTING and HAP: Computer programs for linkage disequilibrium analysis.

Authors:  Jing Hua Zhao
Journal:  Bioinformatics       Date:  2004-02-10       Impact factor: 6.937

4.  AKT3, ANGPTL4, eNOS3, and VEGFA associations with high altitude sickness in Han and Tibetan Chinese at the Qinghai-Tibetan Plateau.

Authors:  Norman E Buroker; Xue-Han Ning; Zhao-Nian Zhou; Kui Li; Wei-Jun Cen; Xiu-Feng Wu; Wei-Zhong Zhu; C Ronald Scott; Shi-Han Chen
Journal:  Int J Hematol       Date:  2012-06-24       Impact factor: 2.490

Review 5.  Human genetic adaptation to high altitude.

Authors:  L G Moore
Journal:  High Alt Med Biol       Date:  2001       Impact factor: 1.981

6.  Paradoxical secondary polycythemia in von Hippel-Lindau patients treated with anti-vascular endothelial growth factor receptor therapy.

Authors:  Stéphane Richard; Laure Croisille; Jeannine Yvart; Nicole Casadeval; Pascal Eschwège; Nozar Aghakhani; Philippe David; Alain Gaudric; Paul Scigalla; Olivier Hermine
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

7.  Effects of high-altitude exposure on vascular endothelial growth factor levels in man.

Authors:  R Walter; M Maggiorini; U Scherrer; J Contesse; W H Reinhart
Journal:  Eur J Appl Physiol       Date:  2001-07       Impact factor: 3.078

8.  Gene expression in the Andes; relevance to neurology at sea level.

Authors:  Otto Appenzeller; Tamara Minko; Vitaly Pozharov; Maurizio Bonfichi; Luca Malcovati; Jorge Gamboa; Luciano Bernardi
Journal:  J Neurol Sci       Date:  2003-03-15       Impact factor: 3.181

Review 9.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

10.  Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain.

Authors:  Heike J Schoch; Silvia Fischer; Hugo H Marti
Journal:  Brain       Date:  2002-11       Impact factor: 13.501

View more
  7 in total

1.  The Local HIF-2α/EPO Pathway in the Bone Marrow is Associated with Excessive Erythrocytosis and the Increase in Bone Marrow Microvessel Density in Chronic Mountain Sickness.

Authors:  Juan Su; Zhanquan Li; Sen Cui; Linhua Ji; Hui Geng; Kexia Chai; Xiaojing Ma; Zhenzhong Bai; Yingzhong Yang; Tana Wuren; Ri-Li Ge; Matthew T Rondina
Journal:  High Alt Med Biol       Date:  2015-12-01       Impact factor: 1.981

2.  The Genetic Architecture of Chronic Mountain Sickness in Peru.

Authors:  Steven Gazal; Jose R Espinoza; Frédéric Austerlitz; Dominique Marchant; Jose Luis Macarlupu; Jorge Rodriguez; Hugo Ju-Preciado; Maria Rivera-Chira; Olivier Hermine; Fabiola Leon-Velarde; Francisco C Villafuerte; Jean-Paul Richalet; Laurent Gouya
Journal:  Front Genet       Date:  2019-07-30       Impact factor: 4.599

3.  Multiple mechanisms drive genomic adaptation to extreme O2 levels in Drosophila melanogaster.

Authors:  Arya Iranmehr; Tsering Stobdan; Dan Zhou; Huiwen Zhao; Sergey Kryazhimskiy; Vineet Bafna; Gabriel G Haddad
Journal:  Nat Commun       Date:  2021-02-12       Impact factor: 14.919

4.  Effect of exercise training in rats exposed to chronic hypoxia: Application for Monge's disease.

Authors:  José-Luis Macarlupu; Dominique Marchant; Florine Jeton; Francisco Villafuerte; Jean-Paul Richalet; Nicolas Voituron
Journal:  Physiol Rep       Date:  2021-04

5.  Association between serum concentrations of hypoxia inducible factor responsive proteins and excessive erythrocytosis in high altitude Peru.

Authors:  Matthew S Painschab; Gary E Malpartida; Victor G Dávila-Roman; Robert H Gilman; Todd M Kolb; Fabiola León-Velarde; J Jaime Miranda; William Checkley
Journal:  High Alt Med Biol       Date:  2015-03-11       Impact factor: 1.981

Review 6.  Chronic Mountain Sickness: Clinical Aspects, Etiology, Management, and Treatment.

Authors:  Francisco C Villafuerte; Noemí Corante
Journal:  High Alt Med Biol       Date:  2016-05-24       Impact factor: 1.981

7.  Whole-Genome Sequencing Identifies the Egl Nine Homologue 3 (egln3/phd3) and Protein Phosphatase 1 Regulatory Inhibitor Subunit 2 (PPP1R2P1) Associated with High-Altitude Polycythemia in Tibetans at High Altitude.

Authors:  Luobu Gesang; Lamu Gusang; Ciren Dawa; Gawa Gesang; Kang Li
Journal:  Dis Markers       Date:  2019-11-07       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.